In a research report issued today, MLV analyst Arlinda Lee maintained a Buy rating on Agios Pharmaceuticals Inc (NASDAQ:AGIO) with a price target …
In a research note issued this morning, MLV analyst Arlinda Lee reiterated a Buy rating on Synta Pharmaceuticals Corp. (NASDAQ:SNTA) with a $6.
In a research report issued today, MLV analyst Arlinda Lee maintained a Buy rating on Halozyme Therapeutics, Inc. (NASDAQ:HALO) with a $20 price target, after the …
MLV’s healthcare analyst Arlinda Lee weighed in today with a few insights on MannKind Corporation (NASDAQ:MNKD), after the company reported its fourth-quarter results, posting EPS of …
In a research report issued today after market close, MLV & Co. analyst Arlinda Lee reiterated a Buy rating on shares of Halozyme Therapeutics, Inc.
In a research report sent to investors today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 …
Before the market opened today, MLV analyst Arlinda Lee reiterated a Buy rating on TG Therapeutics (NASDAQ:TGTX) with a $22 price target, which …
In a research report issued today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 price target, …
In a research report published Friday, MLV analyst Arlinda Lee reiterated a Hold rating on MannKind Corporation (NASDAQ:MNKD) with a price target of …
In a research report sent to investors this morning, MLV analyst Arlinda Lee maintained a Buy rating on Halozyme Therapeutics (NASDAQ:HALO), and raised her …
